Interactions between cytokines and cytotoxic drugs: putative molecular mechanisms in experimental hematology and oncology

Augmentation of the Susceptibility of Human Leukemia to Lymphokine-Activated Killer (LAK) Cells by Exposure of the Leukemic Target Cells to Cytotoxic Drugs in Vitro and in Vivo.

Leukemia & lymphoma·2016

Detection of Minimal Residual Disease in Adult Acute Lymphoblastic Leukemia by Analysis of Gene Rearrangements and Correlation with Early Relapses.

Leukemia & lymphoma·2016

Increasing intensity of therapies assigned at diagnosis does not improve survival of adults with acute myeloid leukemia.

Leukemia·2016

Antileukemic activity of the HSP70 inhibitor pifithrin-μ in acute leukemia.

Blood cancer journal·2012

Clinical and molecular characterization of early T-cell precursor leukemia: a high-risk subgroup in adult T-ALL with a high frequency of FLT3 mutations.

Blood cancer journal·2012

Prognostic impact of meningeal dissemination in primary CNS lymphoma (PCNSL): experience from the G-PCNSL-SG1 trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2012

Microbiome oncolytic virus interactions in cancer: emerging evidence and therapeutic implications for immunotherapy.

Seminars in oncology·2026

Oncolytic viruses in gastrointestinal malignancies: Clinical progress, translational challenges, and future directions.

Seminars in oncology·2026

Bone metastasis in cancer: from microenvironmental remodeling to precision therapy.

Seminars in oncology·2026

Early hepatic decompensation is associated with mortality in patients with HCC treated with atezolizumab plus bevacizumab or durvalumab plus tremelimumab.

Seminars in oncology·2026

Rhabdomyolysis resulting from the interaction of rosuvastatin and abiraterone: A case study.

Seminars in oncology·2026

NK3 subsets are linked to NK cell exhaustion and immunotherapy responsiveness in tumor.

Seminars in oncology·2026

Comparative Cardiovascular Outcomes in Acalabrutinib vs. Zanubrutinib in B-Cell Malignancies: A TriNetX Data Study.

Current oncology (Toronto, Ont.)·2026

Challenges of Conducting a Feasibility Pilot Randomized Controlled Trial During COVID-19 Restrictions: Rivaroxaban Versus Acetyl Salicylic Acid in Patients with Multiple Myeloma on Lenalidomide-Based Therapy (RithMM).

Current oncology (Toronto, Ont.)·2026

Secondary Intracranial Hypertension During ATRA/ATO Therapy in High-Risk Acute Promyelocytic Leukemia: A Case Report and Practical Management Framework.

Current oncology (Toronto, Ont.)·2026

Patient-Reported Burden and Clinical Spectrum of Rheumatic Immune-Related Adverse Events After Immune Checkpoint Inhibitor Therapy in Lung Cancer: A Real-World Cohort Study.

Current oncology (Toronto, Ont.)·2026

Male Sex, Early Postoperative C-Reactive Protein and Prolonged Hospital Stay After Lung Resection in Older Patients: A Retrospective Cohort Study.

Diseases (Basel, Switzerland)·2026

Catalase Activity and Methylglyoxal Concentration in Plasma and Erythrocytes Across Different Clinical Phenotypes of Thyroid Disease: A Cross-Sectional Study.

Diseases (Basel, Switzerland)·2026

Related Experiment Videos

Interactions between cytokines and cytotoxic drugs: putative molecular mechanisms in experimental hematology and

Related Concept Videos

Augmentation of the Susceptibility of Human Leukemia to Lymphokine-Activated Killer (LAK) Cells by Exposure of the Leukemic Target Cells to Cytotoxic Drugs in Vitro and in Vivo.

Detection of Minimal Residual Disease in Adult Acute Lymphoblastic Leukemia by Analysis of Gene Rearrangements and Correlation with Early Relapses.

Increasing intensity of therapies assigned at diagnosis does not improve survival of adults with acute myeloid leukemia.

Antileukemic activity of the HSP70 inhibitor pifithrin-μ in acute leukemia.

Clinical and molecular characterization of early T-cell precursor leukemia: a high-risk subgroup in adult T-ALL with a high frequency of FLT3 mutations.

Prognostic impact of meningeal dissemination in primary CNS lymphoma (PCNSL): experience from the G-PCNSL-SG1 trial.

Microbiome oncolytic virus interactions in cancer: emerging evidence and therapeutic implications for immunotherapy.

Oncolytic viruses in gastrointestinal malignancies: Clinical progress, translational challenges, and future directions.

Bone metastasis in cancer: from microenvironmental remodeling to precision therapy.

Early hepatic decompensation is associated with mortality in patients with HCC treated with atezolizumab plus bevacizumab or durvalumab plus tremelimumab.

Rhabdomyolysis resulting from the interaction of rosuvastatin and abiraterone: A case study.

NK3 subsets are linked to NK cell exhaustion and immunotherapy responsiveness in tumor.

Comparative Cardiovascular Outcomes in Acalabrutinib vs. Zanubrutinib in B-Cell Malignancies: A TriNetX Data Study.

Challenges of Conducting a Feasibility Pilot Randomized Controlled Trial During COVID-19 Restrictions: Rivaroxaban Versus Acetyl Salicylic Acid in Patients with Multiple Myeloma on Lenalidomide-Based Therapy (RithMM).

Secondary Intracranial Hypertension During ATRA/ATO Therapy in High-Risk Acute Promyelocytic Leukemia: A Case Report and Practical Management Framework.

Patient-Reported Burden and Clinical Spectrum of Rheumatic Immune-Related Adverse Events After Immune Checkpoint Inhibitor Therapy in Lung Cancer: A Real-World Cohort Study.

Male Sex, Early Postoperative C-Reactive Protein and Prolonged Hospital Stay After Lung Resection in Older Patients: A Retrospective Cohort Study.

Catalase Activity and Methylglyoxal Concentration in Plasma and Erythrocytes Across Different Clinical Phenotypes of Thyroid Disease: A Cross-Sectional Study.

Related Experiment Videos

Interactions between cytokines and cytotoxic drugs: putative molecular mechanisms in experimental hematology and...

Related Concept Videos

Related Articles

Interactions between cytokines and cytotoxic drugs: putative molecular mechanisms in experimental hematology and